ASX:4DXHealthcare Services
A Look At 4DMedical’s Valuation After Wider Half Year Losses And Stable Revenue
Earnings shock puts 4DMedical’s losses in focus
4DMedical (ASX:4DX) reported half year earnings to 31 December 2025 that kept sales near A$2.85 million, while net loss widened to A$154.14 million and basic loss per share reached A$0.311.
With revenue relatively unchanged from A$2.9 million a year earlier, the size of the current loss compared with A$11.28 million previously is likely to have investors focusing closely on cash use and expense trends.
See our latest analysis for...